Your browser doesn't support javascript.
loading
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint.
Jönsson, Linus; Wimo, Anders; Handels, Ron; Johansson, Gunilla; Boada, Mercè; Engelborghs, Sebastiaan; Frölich, Lutz; Jessen, Frank; Kehoe, Patrick Gavin; Kramberger, Milica; de Mendonςa, Alexandre; Ousset, Pierre Jean; Scarmeas, Nikolaos; Visser, Pieter Jelle; Waldemar, Gunhild; Winblad, Bengt.
Affiliation
  • Jönsson L; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • Wimo A; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • Handels R; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • Johansson G; Department of Psychiatry and Neuropsychology, Maastricht University, Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht, the Netherlands.
  • Boada M; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.
  • Engelborghs S; ACE Alzheimer Center Barcelona - International University of Catalunya, Spain & Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Frölich L; Department of Neurology and Bru-BRAIN, Center for Neurosciences, UZ Brussel & Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Jessen F; Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany.
  • Kehoe PG; Department of Psychiatry, University of Cologne, Faculty of Medicine & University Hospital Cologne, Cologne, Germany.
  • Kramberger M; Department of Neurology, University Medical Centre, Ljubljana & Medical Faculty, University of Ljubljana, Slovenia.
  • de Mendonςa A; Bristol Medical School, Institute of Medical Science, Bristol, UK.
  • Ousset PJ; Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
  • Scarmeas N; Department of Internal Medicine and Clinical Gerontology, Toulouse University Hospital, Toulouse, France.
  • Visser PJ; Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • Waldemar G; Department of Neurology, Columbia University, New York, NY, USA.
  • Winblad B; Department of Psychiatry and Neuropsychology, University of Maastricht & Department of Neurology, Amsterdam Centre, Amsterdam, the Netherlands.
Lancet Reg Health Eur ; 29: 100657, 2023 Jun.
Article in En | MEDLINE | ID: mdl-37251789
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2023 Document type: Article Affiliation country: Sweden Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health Eur Year: 2023 Document type: Article Affiliation country: Sweden Country of publication: United kingdom